(Q30356009)

20 June 2017

1 reference

title

The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD. (English)

1 reference

20 June 2017

0 references

1 reference

1 reference

1

Michaela Diamant

1 reference

20 June 2017

Maarten E Tushuizen

2

1 reference

PubMed ID

16879779

20 June 2017

language of work or name

1 reference

1 August 2006

1 reference

20 June 2017

Current diabetes report

1 reference

20 June 2017

6

1 reference

20 June 2017

4

1 reference

20 June 2017

279-286

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-006-0061-4

20 June 2017

0 references

cites work

Endothelial dysfunction: cause of the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0061-4

Blood flow and muscle metabolism: a focus on insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0061-4

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0061-4

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0061-4

Atherogenesis: a postprandial phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0061-4

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0061-4

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0061-4

The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes.

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

1 reference

12 December 2020

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.

1 reference

12 December 2020

Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes

1 reference

12 December 2020

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women

1 reference

12 December 2020

The clinical implications of endothelial dysfunction

1 reference

12 December 2020

Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.

1 reference

12 December 2020

Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study

1 reference

12 December 2020

Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia

1 reference

12 December 2020

Two consecutive high-fat meals affect endothelial-dependent vasodilation, oxidative stress and cellular microparticles in healthy men.

1 reference

12 December 2020

A central role for JNK in obesity and insulin resistance

1 reference

12 December 2020

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

1 reference

12 December 2020

Inflammation as a cardiovascular risk factor

1 reference

12 December 2020

Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease

1 reference

12 December 2020

A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes

1 reference

12 December 2020

Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes

1 reference

12 December 2020

The pathobiology of diabetic complications: a unifying mechanism

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells

1 reference

12 December 2020

Homocysteine lowering with folic acid and B vitamins in vascular disease

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Adipose tissue as source and target for novel therapies

1 reference

12 December 2020

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

1 reference

12 December 2020

Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes

1 reference

12 December 2020

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

1 reference

12 December 2020

Impact of the renin-angiotensin system on lipid and carbohydrate metabolism.

1 reference

12 December 2020

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

1 reference

12 December 2020

Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome

1 reference

12 December 2020

Role of endothelial dysfunction in insulin resistance

1 reference

12 December 2020

Testing endothelial vasomotor function: nitric oxide, a multipotent molecule

1 reference

12 December 2020

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

The burden of mortality attributable to diabetes: realistic estimates for the year 2000

1 reference

12 December 2020

Insulin signalling and the regulation of glucose and lipid metabolism

1 reference

12 December 2020

Insulin resistance and endothelial dysfunction

1 reference

12 December 2020

Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.

1 reference

12 December 2020

Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome

1 reference

12 December 2020

The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial

1 reference

12 December 2020

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

1 reference

12 December 2020

"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.

1 reference

12 December 2020

Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease

1 reference

12 December 2020

Reactive oxygen species have a causal role in multiple forms of insulin resistance

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

1 reference

12 December 2020

Endothelial function: cardiac events

1 reference

12 December 2020

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

1 reference

12 December 2020

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial

1 reference

12 December 2020

Adipose tissue, inflammation, and cardiovascular disease

1 reference

12 December 2020

Homocysteine lowering and cardiovascular events after acute myocardial infarction

1 reference

12 December 2020

Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited

1 reference

12 December 2020

Physiological concentrations of insulin induce endothelin-dependent vasoconstriction of skeletal muscle resistance arteries in the presence of tumor necrosis factor-alpha dependence on c-Jun N-terminal kinase

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.

1 reference

12 December 2020

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Epidemiologic and economic consequences of the global epidemics of obesity and diabetes

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm

1 reference

12 December 2020

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

1 reference

12 December 2020

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation

1 reference

12 December 2020

Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence

1 reference

12 December 2020

Mitochondrial dysfunction and type 2 diabetes

1 reference

12 December 2020

Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase

1 reference

12 December 2020

Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus

1 reference

12 December 2020

10.1007/S11892-006-0061-4

Identifiers

DOI

1 reference

PubMed ID

16879779

Dimensions Publication ID

20 June 2017

0 references

1 reference

PubMed ID

16879779